This company seems to have been delisted
Reason: Acquired by Alfasigma
Last recorded trade on: January 10, 2024
Source: https://www.alfasigma.com/corporate/alfasigma-completes-acquisition-of-intercept-pharmaceuticals-inc/
Reason: Acquired by Alfasigma
Last recorded trade on: January 10, 2024
Source: https://www.alfasigma.com/corporate/alfasigma-completes-acquisition-of-intercept-pharmaceuticals-inc/
Intercept Pharmaceuticals
ICPT
$27.06
Share price
0.00%
Change (1 day)
-3.29%
Change (1 year)
Categories
Earnings for Intercept Pharmaceuticals (ICPT)
Earnings in 2023 (TTM): -C$78.39 Million
According to Intercept Pharmaceuticals 's latest financial reports the company's current earnings are C$0.31 Billion. In 2022 the company made an earning of -C$0.23 Billion a decrease over its 2021 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Intercept Pharmaceuticals from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -C$78.39 Million | -65.44% |
| 2022 | -C$0.23 Billion | 74.17% |
| 2021 | -C$0.14 Billion | -66.74% |
| 2020 | -C$0.4 Billion | -20.25% |
| 2019 | -C$0.5 Billion | 11.46% |
| 2018 | -C$0.45 Billion | -14.19% |
| 2017 | -C$0.52 Billion | -12.71% |
| 2016 | -C$0.59 Billion | 82.32% |
| 2015 | -C$0.33 Billion | -23.21% |
| 2014 | -C$0.43 Billion | 334.95% |
| 2013 | -C$96.57 Million | 60.48% |
| 2012 | -C$60.18 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | C$18.06 B | -21,958.99% | 🇺🇸 USA |
 | -C$11.94 Billion | 14,344.06% | 🇺🇸 USA |
 | C$0.98 B | -1,289.45% | 🇺🇸 USA |
 | -C$15.74 Million | -80.96% | 🇺🇸 USA |